Validation study of the modified Drug Resistance in Pneumonia (mDRIP) score in identifying infections with drug-resistant pathogens among hospitalized patients with community-acquired pneumonia at the Chinese General Hospital and Medical Center
Philippine Journal of Chest Diseases · 25.06.2026 · 24 (1) · 29-35
DOI: 10.70172/pjcd38114477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philippine Journal of Chest Diseases, online erschienen am 25.06.2026. Verfasst von Cynthia Charmino und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Community-acquired pneumonia (CAP) continues to be the leading cause of infection-related deaths globally and is the fourth leading cause of both morbidity and mortality in the Philippines. Despite the development of novel vaccines, antibiotics, and rapid diagnostic tests, managing CAP remains challenging, especially with the emergence of drug-resistant pathogens (DRP). The modified Drug Resistance in Pneumonia (mDRIP) score is a scoring system which was derived from locally-relevant clinical risk factors that can predict infections with DRP. The performance of mDRIP score in identifying infections with DRP among patients with CAP was evaluated in this cross-sectional study. Methodology: A total of 127 participants with CAP were included. The mDRIP score was calculated upon admission. Antimicrobial culture results were later obtained and clinical outcomes were ascertained. The mDRIP score performance was assessed by determining the relevant performance metrics using area under the receiver operating characteristic curve (AUC-ROC). Clinical outcomes were compared between patients with DRP and those without.
Results
The prevalence of drug-resistant pathogens in the study was 40.16%. The most common organism isolated was Klebsiella pneumoniae. Among the major and minor risk factors for drug resistance included in the mDRIP score, the most common were recent antibiotic use (46.46%) and poor functional status (47.24%), respectively. The discrimination performance of the mDRIP score was good, with an AUC-ROC value of 0.868 (95% CI 0.801 to 0.935). There was no statistically significant difference in the length of hospital stay and hospital outcome between those with and without DRP.
Conclusions
The mDRIP score demonstrates good performance in identifying infections due to DRP in CAP. It is an accessible and effective risk stratification tool that can be utilized by clinicians for appropriate selection of antibiotics in CAP, especially in resource-limited settings.
Zitieren
APA
Charmino, C., & Dy-Sebastian, C. G. (2026). Validation study of the modified Drug Resistance in Pneumonia (mDRIP) score in identifying infections with drug-resistant pathogens among hospitalized patients with community-acquired pneumonia at the Chinese General Hospital and Medical Center. Philippine Journal of Chest Diseases, 24(1), 29-35. https://doi.org/10.70172/pjcd38114477
Vancouver
Charmino C, Dy-Sebastian CG. Validation study of the modified Drug Resistance in Pneumonia (mDRIP) score in identifying infections with drug-resistant pathogens among hospitalized patients with community-acquired pneumonia at the Chinese General Hospital and Medical Center. Philippine Journal of Chest Diseases. 2026;24(1):29-35. doi:10.70172/pjcd38114477
BibTeX
@article{Charmino2026,
author = {Charmino, Cynthia and Dy-Sebastian, Cristalle Geraldine},
title = {Validation study of the modified Drug Resistance in Pneumonia (mDRIP) score in identifying infections with drug-resistant pathogens among hospitalized patients with community-acquired pneumonia at the Chinese General Hospital and Medical Center},
journal = {Philippine Journal of Chest Diseases},
year = {2026},
volume = {24},
number = {1},
pages = {29--35},
doi = {10.70172/pjcd38114477}
}
EUVIMED